km.idaeo.ai · IDAEO 知識庫

🏛 本文屬於主題館「reports」 →

植牙會後悔嗎？網友的慘痛經驗是真的嗎？｜證據鏈

km 編輯部2026-08-13閱讀約 40 分鐘
#證據鏈#牙醫KM#台灣#植牙

本頁是〈植牙會後悔嗎？網友的慘痛經驗是真的嗎？〉的事實單元帳：每一條主張對應的來源、證據等級、地域與期間、原文引句與限制，逐條攤開。

植牙會後悔嗎？網友的慘痛經驗是真的嗎？｜證據鏈

F-Units（事實單元帳）

  • F1｜confidence: verified｜basis: peer_reviewed（PMID 40523497）｜period: 2025 刊出，依 2017 World Workshop 標準｜geo: universal｜span: 「The weighted mean prevalence of peri-implant mucositis was 63.0 % (CI: 57.6-68.2 %) at the patient level and 59.2 % (CI: 55.8-62.4 %) at the implant level」「Peri-implantitis was observed in 25.0 % (CI: 21.1-29.3 %) of patients and 18.0 % (CI: 15.8-20.5 %) of implants」「In non-smokers, the implant-level prevalence of peri-implant mucositis and peri-implantitis was 38.2 % (CI: 33.4-43.2 %) and 5.2 % (CI: 3.6-7.5 %), respectively」「The risk of bias was high in 50 %, moderate in 45 %」「The findings highlight the high worldwide prevalence of peri-implant diseases, emphasizing the need for uniform diagnostic protocols」｜caveat: 納入 20 篇橫斷研究，偏誤風險高者占半數；群體盛行率非個人風險
  • F2｜confidence: verified｜basis: peer_reviewed（PMID 36261829）｜period: 檢索 2005-01 至 2021-12，2022 刊出｜geo: universal｜span: 「Prevalence of peri-implantitis was 19.53% (95% CI 12.87-26.19) at the patient-level, and 12.53% (95% CI 11.67-13.39) at the implant-level and it remains highly variable even following restriction to the clinical case definition」「estimates of its prevalence fluctuate very much. This may be due to the wide variety of disease definitions」｜caveat: 57 篇納入；作者明指定義差異造成變異
  • F3｜confidence: verified｜basis: clinical_guideline（PMID 25626479，第 11 屆歐洲牙周病學工作坊共識報告）｜period: 2015 刊出｜geo: universal｜span: 「The management of peri-implant mucositis is considered as a preventive measure for the onset of peri-implantitis」「meta-analysis estimated a weighted mean prevalence for peri-implant mucositis of 43% (CI: 32-54%) and for peri-implantitis of 22% (CI: 14-30%)」「lack of regular supportive therapy in patients with peri-implant mucositis was associated with increased risk for onset of peri-implantitis」「whereas plaque accumulation has been established as aetiological factor, smoking was identified as modifiable patient-related and excess cement as local risk indicator」「patient-administered mechanical plaque control (with manual or powered toothbrushes) has been shown to be an effective preventive measure」「implant placement and prosthetic reconstructions need to allow proper personal cleaning, diagnosis by probing and professional plaque removal」｜caveat: 共識報告，建議層級非個別處置指示
  • F4｜confidence: verified｜basis: peer_reviewed（PMID 30904559）｜period: 檢索 1997 至 2018-01，2019 刊出｜geo: universal｜span: 「The summary estimate for 10-year survival at the implant level was 96.4% (95% CI 95.2%-97.5%)」「The sensitivity meta-analysis summary estimate of survival was 93.2% (95% CI 90.1% to 95.8%)」「demonstrated a possible doubling of the risk of implant loss in the older age groups」｜caveat: 18 篇前瞻觀察研究；存活率＝植體仍在口內，非「無併發症」
  • F5｜confidence: verified｜basis: peer_reviewed（PMID 39305362）｜period: 2024 刊出｜geo: universal｜span: 「Three prospective studies (n = 237 implants) revealed a mean implant survival rate of 92% (95% CI: 82% to 97%), decreasing to 78% (95% CI: 74%-82%) after imputation」「A total of five retrospective studies (n = 1440 implants) showed a survival rate of 88% (95% CI: 78%-94%)」「follow-up is essential and shouldn't end after insertion or even after 10 years」｜caveat: 樣本數小（前瞻 237 支）；限粗糙表面螺旋狀鈦植體；插補前後差距即為失訪處理造成，不可只引其一
  • F6｜confidence: verified｜basis: peer_reviewed（PMID 39466662）｜period: 檢索至 2024-04，2025 刊出｜geo: universal｜span: 「HP patients had a significantly greater risk for implant loss (HR: 1.75; 95% CI: 1.28-2.40; p = 0.0005」「and peri-implantitis (3.24; 95% CI: 1.58-6.64; p = 0.001」「a history of periodontitis has been proved to significantly increase the risk for implant loss, particularly at long follow-up」｜caveat: 14 篇前瞻世代；作者標註病例定義與評估方法異質
  • F7｜confidence: verified｜basis: peer_reviewed（PMID 23062125）｜period: 平均追蹤 ≥5 年，2012 刊出｜geo: universal｜span: 「Only 66.4% of the patients were free of any complications after 5 years」「fractures of the veneering material (13.5%), peri-implantitis and soft tissue complications (8.5%), loss of access hole restoration (5.4%), abutment or screw loosening (5.3%), and loss of retention of cemented FDPs (4.7%)」「biological and technical complications were frequent (33.6%)」｜caveat: 限植體支撐固定牙橋；2012 年文獻，材料世代已有變化
  • F8｜confidence: verified｜basis: peer_reviewed（PMID 23062124）｜period: 平均追蹤 ≥5 年，2012 刊出｜geo: universal｜span: 「survival of implants supporting SCs at 5 years amounted to 97.2% (95% CI: 96.3-97.9%), and at 10 years amounted to 95.2% (95% CI: 91.8-97.2%)」「The survival of implant-supported SCs was 96.3% (95% CI: 94.2-97.6%) after 5 years and 89.4% (95% CI: 82.8-93.6%) after 10 years」「a cumulative incidence of 8.8% (95% CI: 5.1-15.0%) for screw-loosening, 4.1% (95% CI: 2.2-7.5%) for loss of retention, and 3.5% (95% CI: 2.4-5.2%) for fracture of the veneering material after 5 years」「The cumulative 5-year aesthetic complication rate amounted to 7.1% (95% CI: 3.6-13.6%)」｜caveat: 限單顆植體牙冠；植體存活與牙冠存活是兩個指標
  • F9｜confidence: verified｜basis: peer_reviewed（PMID 30109300）｜period: 2018 刊出，16 篇納入｜geo: universal｜span: 「Patients had high expectations, with function followed by aesthetics being the most important expected improvements」「Costs were a major factor against implant-based therapy」「The expectations that implants will last a lifetime and require no special needs of oral hygiene were of concern」「Prior to treatment, patients have high expectations of implant therapy. In general, these expectations are met」｜caveat: 研究設計異質，作者指出可比較性受限
  • F10｜confidence: verified｜basis: peer_reviewed（PMID 40192114）｜period: 2025 刊出｜geo: universal｜span: 「The incidence of neurosensory alterations in patients with implants placed at a distance ≥ 2 mm from the mandibular canal was 0%」「for implants placed at a distance of 0-1 mm from the mandibular canal, the incidence of neurosensory alterations was 68%」「patients with implants that intruded into the canal had an incidence of 53% in the development of neurosensorial alterations」「Clinicians should be aware of the potential risk of nerve injury and adopt appropriate precautions, including meticulous preoperative planning and three-dimensional radiographic images」｜caveat: 0% 為該研究特定分層下的觀察值，不等於該距離下不會發生；解讀須連同分層條件與樣本規模
  • F11｜confidence: verified（同 #28 卡 F15 錨）｜basis: peer_reviewed（PMID 34074573）｜period: 1997 至 2013 全國登錄，2022 刊出｜geo: universal｜span: 「other implant-related complications (infection, implant malposition, lack of bone at implant site, mechanical damage, or failed osseointegration)」｜caveat: 芬蘭理賠登錄；僅用於「神經損傷屬已知併發症類別」
  • F12｜confidence: verified｜basis: peer_reviewed（PMID 39286589）｜period: 納入 2007 至 2020 文獻，2024 刊出｜geo: universal｜span: 「The selected studies highlighted several aesthetic issues, such as recession, marginal bone loss, gingival loss, and pink aesthetic scores related to dental implants placed in the aesthetic zone」「Addressing these challenges necessitates meticulous treatment planning, effective soft tissue management, regular follow-ups, patient education, expectation management, and collaborative efforts among specialists」｜caveat: 14 篇納入、時間窗較窄，作者自陳外推性受限
  • F13｜confidence: verified｜basis: peer_reviewed（PMID 25358599）｜period: 2014 刊出｜geo: universal｜span: 「Most studies are cross sectional in nature and the quality of reporting varies considerably」「Expectations with respect to aesthetics and function are key attributes considered」｜caveat: 敘事性回顧，無法進行統合分析
  • F14｜confidence: verified｜basis: peer_reviewed（PMID 26701350）｜period: 檢索至 2015-06，2016 刊出｜geo: universal｜span: 「implant therapy must not be limited to the placement and restoration of dental implants but to the implementation of PIMT」「our findings suggest reason to claim a minimum recall PIMT interval of 5 to 6 mo」「even in the establishment of PIMT, biologic complications might occur」｜caveat: 作者明示須依個人風險輪廓調整；非固定處方
  • F15｜confidence: verified｜basis: peer_reviewed（PMID 39393606）｜period: 檢索至 2024-06，2024 刊出｜geo: universal｜span: 「At implant level, a meta-analysis of 21 included cohort studies showed that smoking was associated with increased risk of early dental implant failure compared with non-smoking (odds ratio [OR], 2.59; 95 % confidence interval [CI], 2.08-3.23)」「with a total of 59,246 implants at implant level and 14,115 patients at individual level」｜caveat: 觀察性研究合併，非因果推論；OR 2.59 出自 32 篇中的 21 篇世代研究、植體層級，勿與個人層級 OR 2.00 混用
  • F16｜confidence: verified（2026-08-06 以 ego-browser 實載逐字比對；同 VERIFIED-FACTS.md 錨）｜basis: law｜period: 現行條文｜geo: TW｜span: 《全民健康保險法》第 51 條「十一、義齒、義眼、眼鏡、助聽器、輪椅、拐杖及其他非具積極治療性之裝具。」｜caveat: 個別項目給付以健保署現行公告為準，本卡不作給付判定
  • F17｜confidence: verified（同 #28 卡 F8 錨）｜basis: peer_reviewed（PMID 35056347）｜period: 2021 刊出，292 篇納入｜geo: universal｜span: 「implants in smokers had a higher failure risk in comparison with non-smokers (OR 2.402, p < 0.001)」｜caveat: 觀察性證據合併，非因果推論
  • F18｜confidence: verified（2026-08-06 以 ego-browser 實載，頁面逐字顯示提供機關）｜basis: official_statement｜period: 資料集現況（詮釋資料更新時間 2026-07-13）｜geo: TW｜span: 政府資料開放平臺資料集「臺北市醫療收費標準」，提供機關「臺北市政府衛生局」｜caveat: 單一縣市例證，其他縣市頁面放量前逐一補驗；另據 VERIFIED-FACTS.md（2026-08-05 OP 以 ego-browser 逐項實測）健保署「醫材比價網」兩軌品項類別皆不含牙科，牙科自費項目不得以該網作為查證管道，本卡查證陷阱一段即據此
  • F19｜confidence: verified｜basis: peer_reviewed（PMID 23543525，Cochrane 系統性回顧）｜period: 檢索至 2012-06，2013 刊出｜geo: universal｜span: 「dental implants are kept load-free for 3 to 8 months to establish osseointegration (conventional loading)」「immediate (within 1 week), early (between 1 week and 2 months), and conventional (after 2 months) loading of osseointegrated implants」「the mean rate of implant failure in all 26 trials was a low 2.5%」「having a follow-up of 4 months to 1 year」｜caveat: 2.5% 為納入試驗 4 個月至 1 年追蹤窗之短期數字，不可與 10 年、20 年數字互換；負載時機屬臨床判斷
  • F20｜confidence: verified（2026-08-06 以 ego-browser 實載逐字比對）｜basis: law｜period: 現行條文｜geo: TW｜span: 《醫療法》第 63 條「醫療機構實施手術，應向病人或其法定代理人、配偶、親屬或關係人說明手術原因、手術成功率或可能發生之併發症及危險，並經其同意，簽具手術同意書及麻醉同意書，始得為之。」｜caveat: 條文引述，非法律意見
  • F21｜confidence: verified（2026-08-06 以 ego-browser 實載逐字比對）｜basis: law｜period: 現行條文｜geo: TW｜span: 《醫療法》第 81 條「醫療機構診治病人時，應向病人或其法定代理人、配偶、親屬或關係人告知其病情、治療方針、處置、用藥、預後情形及可能之不良反應。」｜caveat: 條文引述，非法律意見
  • F22｜confidence: verified（同 #28 卡 F10 錨）｜basis: peer_reviewed（PMID 36807599）｜period: 檢索至 2022-08，2023 刊出｜geo: universal｜span: 「diabetic patients with dental implants and good glycaemic control have a significantly lower risk of peri-implantitis (odds ratio [OR] = 0.16」「risk of dental implant failure (OR = 3.76; 95% CI: 1.50-9.45; I2 : 0%) appears to be greater under irregular or no SPC」｜caveat: 間接證據，作者標註證據侷限
  • F23｜confidence: verified｜basis: peer_reviewed（PMID 30328195）｜period: 追蹤 ≥3 年之研究，2018 刊出｜geo: universal｜span: 「Therapy of peri-implantitis followed by regular supportive care resulted in high patient- and implant-level survival in the medium to long term」「Favourable results were reported, with clinical improvements and stable peri-implant bone levels in the majority of patients」｜caveat: 研究設計與病例定義異質，作者指出報告品質影響資料萃取
  • F24｜confidence: 結構性整理（編輯框架，非外部事實宣稱）｜basis: editorial_framework｜period: 2026-08-06｜geo: universal｜span: 「不引用也不否定網路論壇貼文」之處理原則、將常見抱怨對應到文獻併發症類別的五類分流框架、「存活率須連著追蹤年限與族群一起看」之閱讀規則、費用問法與查證陷阱提示（牙科不在健保署醫材比價網品項範圍，見 VERIFIED-FACTS.md 2026-08-05 實測）｜caveat: 編輯性溝通框架，非診斷工具、不取代臨床判斷
  • F25｜confidence: verified｜basis: peer_reviewed（PMID 37339881）｜period: 檢索至 2022-07-21，2023 刊出｜geo: universal｜span: 「Provision of SPIC following peri-implantitis therapy may prevent disease recurrence or progression」「with recall intervals varying between 2 months and annually」「Insufficient evidence is available to identify (i) a specific supportive care protocol for secondary prevention of peri-implantitis」｜caveat: 15 篇納入、異質性高致未做統合分析
  • F26｜confidence: verified｜basis: peer_reviewed（PMID 27183062）｜period: 檢索至 2014-11，2016 刊出｜geo: universal｜span: 「The survival rate for implant replacement at the second attempt was 88.84% (390/439; range, 71% to 94.6%)」「Thirty-one implants were replaced for a third attempt with a mean survival rate of 74.19% (23/31)」「Implant replacement is a reasonably feasible option for scenarios of early and late implant failure. However, modifiable risk factors must be controlled before proceeding for implant replacement」｜caveat: 僅 7 篇（5 回溯世代＋2 病例系列）；第三次植入樣本 31 支，區間寬
  • F27｜confidence: verified｜basis: internal_dataset｜period: 2025-03 至 2026-08 GSC｜geo: TW｜span: backlog #7「植牙後悔」「植牙慘痛經驗ptt」等 11 詞項合計曝光 270,300，跨 6 站｜caveat: 曝光為資產級數字、非去重流量；發布轉檔時本條不輸出（08-05 內部數據不進可見層裁定）
  • F28｜confidence: verified（2026-08-06 以 ego-browser 實載逐字比對）｜basis: law｜period: 現行條文｜geo: TW｜span: 《醫療法》第 87 條「廣告內容暗示或影射醫療業務者，視為醫療廣告。醫學新知或研究報告之發表、病人衛生教育、學術性刊物，未涉及招徠醫療業務者，不視為醫療廣告。」｜caveat: 條文引述，非法律意見

來源清單

取用日期均為 2026-08-06；PubMed 條目以 E-utilities efetch 取得摘要原文並逐條逐字比對，台灣法規與官方資料以 ego-browser 實載頁面逐字比對。

  1. Reis INRD, et al. The prevalence of peri-implant mucositis and peri-implantitis based on the world workshop criteria: A systematic review and meta-analysis. J Dent. 2025;160:105914. PMID 40523497
  2. Diaz P, et al. What is the prevalence of peri-implantitis? A systematic review and meta-analysis. BMC Oral Health. 2022;22(1):449. PMID 36261829
  3. Jepsen S, et al. Primary prevention of peri-implantitis: managing peri-implant mucositis. J Clin Periodontol. 2015;42 Suppl 16:S152-7. PMID 25626479
  4. Howe MS, Keys W, Richards D. Long-term (10-year) dental implant survival: A systematic review and sensitivity meta-analysis. J Dent. 2019;84:9-21. PMID 30904559
  5. Kupka JR, et al. How far can we go? A 20-year meta-analysis of dental implant survival rates. Clin Oral Investig. 2024;28(10):541. PMID 39305362
  6. Annunziata M, et al. Effectiveness of Implant Therapy in Patients With and Without a History of Periodontitis: A Systematic Review With Meta-Analysis of Prospective Cohort Studies. J Periodontal Res. 2025;60(6):524-543. PMID 39466662
  7. Pjetursson BE, et al. A systematic review of the survival and complication rates of implant-supported fixed dental prostheses (FDPs) after a mean observation period of at least 5 years. Clin Oral Implants Res. 2012;23 Suppl 6:22-38. PMID 23062125
  8. Jung RE, et al. Systematic review of the survival rate and the incidence of biological, technical, and aesthetic complications of single crowns on implants reported in longitudinal studies with a mean follow-up of 5 years. Clin Oral Implants Res. 2012;23 Suppl 6:2-21. PMID 23062124
  9. Korfage A, et al. Patients' expectations of oral implants: a systematic review. Eur J Oral Implantol. 2018;11 Suppl 1:S65-S76. PMID 30109300
  10. Peña-Cardelles JF, et al. Inferior alveolar nerve damage related to dental implant placement. A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2025;30(4):e578-e589. PMID 40192114
  11. Pääsky E, et al. Are women more susceptible than men to iatrogenic inferior alveolar nerve injury in dental implant surgery? Int J Oral Maxillofac Surg. 2022;51(2):251-256. PMID 34074573
  12. Alanazi S. Aesthetic problems related to dental implants in the aesthetic zone: A systematic review. Saudi Dent J. 2024;36(9):1179-1183. PMID 39286589
  13. Yao J, et al. Patients' expectations to dental implant: a systematic review of the literature. Health Qual Life Outcomes. 2014;12:153. PMID 25358599
  14. Monje A, et al. Impact of Maintenance Therapy for the Prevention of Peri-implant Diseases: A Systematic Review and Meta-analysis. J Dent Res. 2016;95(4):372-9. PMID 26701350
  15. Fan YY, et al. Smoking in relation to early dental implant failure: A systematic review and meta-analysis. J Dent. 2024;151:105396. PMID 39393606
  16. 全民健康保險法 第 51 條（全國法規資料庫）
  17. Mustapha AD, et al. Smoking and Dental Implants: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2021;58(1):39. PMID 35056347
  18. 政府資料開放平臺：臺北市醫療收費標準（提供機關：臺北市政府衛生局）
  19. Esposito M, et al. Interventions for replacing missing teeth: different times for loading dental implants. Cochrane Database Syst Rev. 2013;(3):CD003878. PMID 23543525
  20. 醫療法 第 63 條（全國法規資料庫）
  21. 醫療法 第 81 條（全國法規資料庫）
  22. Carra MC, et al. Primordial and primary prevention of peri-implant diseases: A systematic review and meta-analysis. J Clin Periodontol. 2023;50 Suppl 26:77-112. PMID 36807599
  23. Roccuzzo M, et al. Clinical outcomes of peri-implantitis treatment and supportive care: A systematic review. Clin Oral Implants Res. 2018;29 Suppl 16:331-350. PMID 30328195
  24. 編輯框架：本站「不引用也不否定論壇貼文」原則與五類對照結構（無外部來源，標示為結構性整理）
  25. Stiesch M, et al. Supportive care for the prevention of disease recurrence/progression following peri-implantitis treatment: A systematic review. J Clin Periodontol. 2023;50 Suppl 26:113-134. PMID 37339881
  26. Zhou W, et al. Feasibility of Dental Implant Replacement in Failed Sites: A Systematic Review. Int J Oral Maxillofac Implants. 2016;31(3):535-45. PMID 27183062
  27. 內部數據：`analysis/reports/km-dental-backlog.md` #7 附錄（詞×站×曝光逐筆可對帳）
  28. 醫療法 第 87 條（全國法規資料庫）

內部引用鏈

  • 併發症同族（補骨端的後遺症、失敗與紅旗徵象）：補骨粉會有後遺症嗎？失敗了會怎樣？（KM-DENTAL-28）
  • 費用期待同族（報價單由哪四塊組成、怎麼比才不會比錯）：植牙一顆到底多少錢？（KM-DENTAL-09）
  • 術後照護同族（植牙後多久能吃東西、咖啡與茶）：植牙後多久能吃東西？（KM-DENTAL-20）
發布閘門提醒：本卡為 draft。四語（zh-Hans／en／ja）未產前不得進 km_entries；F27 內部數據與 frontmatter 之曝光欄位於發布轉檔時剝除，不進可見層。

FAQ

網路上那些「植牙慘痛經驗」是真的嗎？
**無法逐則查證，本卡不引用也不否定 [F24]。** 但貼文抱怨的類型在文獻中都有對應：植體周圍疾病 [F1][F2][F3]、植體失敗 [F4][F5]、神經感覺異常 [F10][F11]、假牙端併發症 [F7][F8][F12]、期待落差 [F9]。與其判斷貼文真假，不如把這五類逐項帶進診間問。
ネットの「インプラントのつらい体験談」は本当ですか？ — **一件ずつ検証できないため、本カードは引用も否定もしません [F24]。** ただし不満の型には、インプラント周囲疾患 [F1][F2][F3]、インプラント失敗 [F4][F5]、神経感覚異常 [F10][F11]、補綴物合併症 [F7][F8][F12]、期待のずれ [F9] という文献上の対応があります。投稿の真偽を決めるより、この五つを診察室で順に尋ねてください。
Are those online “dental implant horror stories” real? — **They cannot be verified one by one; this card neither cites nor dismisses them [F24].** The kinds of complaints do, however, correspond to categories in the literature: peri-implant diseases [F1][F2][F3], implant failure [F4][F5], neurosensory alterations [F10][F11], prosthetic complications [F7][F8][F12], and expectation gaps [F9]. Rather than decide whether a post is true, take these five categories into the consultation one at a time.
植牙可以用一輩子嗎？
**現有文獻只提供有追蹤年限的存活率，沒有「用一輩子」這種結論。** 針對病人期待的系統性回顧直接把「植體可以用一輩子」與「不需要特別的口腔衛生照護」列為值得關注的期待 [F9]。可查證的是有追蹤年限的存活率：10 年植體層級 96.4%、敏感度分析 93.2% [F4]；20 年前瞻性研究 92%、插補後 78%、回溯性研究 88% [F5]。而假牙端的 5 年併發症合計 33.6% [F7]。這些是群體層級的數字，不能推估個人結果。
インプラントは一生使えますか？ — **現行文献が示すのは追跡期間つきの生存率であり、「一生使える」という結論ではありません。** 患者の期待のシステマティックレビューは、「インプラントは一生もつ」「特別な口腔衛生ケアは不要」を懸念すべき期待として直接挙げています [F9]。確認できるのは追跡期間つき生存率です。10 年のインプラントレベルで 96.4%、感度分析で 93.2% [F4]、20 年の前向き研究で 92%、補完後 78%、後ろ向き研究で 88% [F5] でした。補綴物側の 5 年合計合併症は 33.6% でした [F7]。これらは集団レベルの数値で、個人の結果は予測できません。
Can an implant last a lifetime? — **Available literature provides survival figures with follow-up periods, not a conclusion that an implant lasts “a lifetime.”** A systematic review of patient expectations explicitly identifies “implants will last a lifetime” and “no special oral-hygiene care is needed” as expectations of concern [F9]. Verifiable figures have follow-up periods: implant-level survival was 96.4% at 10 years and 93.2% in sensitivity analysis [F4]; prospective 20-year studies reported 92%, falling to 78% after imputation, while retrospective studies reported 88% [F5]. Prosthetic complications totalled 33.6% at 5 years [F7]. These are population-level figures and cannot predict an individual outcome.
植牙失敗了還能再做嗎？
**文獻記錄的是群體層級的可行性，不是個人的處置建議。** 在先前失敗部位重植，第二次的存活率為 88.84%、第三次為 74.19%（僅 31 支）；該回顧同時要求重植前先控制可改變的風險因素 [F26]。植體周圍炎方面，一份系統性回顧記錄了治療後接受規律支持性照護者在中長期的存活結果偏向正面，但同時寫明納入研究的病例定義、治療方式與族群差異明顯，不能據此預測個人療效 [F23]；支持性照護的具體方案，現有證據也仍不足以指定 [F25]。要不要重做、何時重做，須由牙醫師評估。
インプラントが失敗したら、もう一度できますか？ — **文献が記録しているのは集団レベルの実行可能性であり、個人への処置提案ではありません。** 既に失敗した部位での再植立は、二回目の生存率 88.84%、三回目 74.19%（31 本のみ）で、同レビューは再植立前に変更可能なリスク因子を管理するよう求めています [F26]。インプラント周囲炎については、治療後に定期的な支持的ケアを受けた人の中長期の生存結果は良好な傾向でしたが、症例定義、治療、集団の差が大きく、個人の効果は予測できないとも記されています [F23]。支持的ケアの具体的な手順を指定できるほどの根拠もありません [F25]。再治療するか、いつするかは歯科医師の評価が必要です。
If an implant fails, can it be done again? — **The literature documents population-level feasibility, not treatment advice for an individual.** At previously failed sites, survival for the second attempt was 88.84% and for the third attempt 74.19% (only 31 implants); the review also requires modifiable risk factors to be controlled before reimplantation [F26]. For peri-implantitis, a systematic review reported favourable medium- to long-term survival findings after treatment followed by regular supportive care, but also described substantial differences in case definitions, treatments, and populations, so it cannot predict individual effectiveness [F23]. Available evidence also remains insufficient to specify a particular supportive-care protocol [F25]. Whether and when to repeat treatment requires assessment by a dentist.

來源錨定

引用本文

km 編輯部・《植牙會後悔嗎？網友的慘痛經驗是真的嗎？｜證據鏈》・IDAEO 知識庫・2026-08-13・https://km.idaeo.ai/reports/dental-implant-regret-evidence

相關文章

更新 2026-08-13T14:17:18.591Z · server-rendered · four-language · IDAEO 知識庫